Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden
Authors
Keywords
-
Journal
ANNALS OF NUCLEAR MEDICINE
Volume 35, Issue 9, Pages 1022-1029
Publisher
Springer Science and Business Media LLC
Online
2021-06-14
DOI
10.1007/s12149-021-01637-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas
- (2020) Talia C. Oughourlian et al. JOURNAL OF NEURO-ONCOLOGY
- Flare phenomenon in O-(2-[18F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas
- (2020) Christian P Filss et al. JOURNAL OF NUCLEAR MEDICINE
- Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
- (2020) Annette M. Molinaro et al. JAMA Oncology
- World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient
- (2020) John Maynard et al. RADIOLOGY
- Voxel-Wise and Patient-Wise Correlation of 18F-FDOPA PET, rCBV, and ADC in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes
- (2020) Hiroyuki Tatekawa et al. JOURNAL OF NUCLEAR MEDICINE
- Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
- (2019) A. Lasocki et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- An independently validated survival nomogram for lower-grade glioma
- (2019) Haley Gittleman et al. NEURO-ONCOLOGY
- 18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy
- (2018) Bogdana Suchorska et al. JOURNAL OF NEURO-ONCOLOGY
- Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning
- (2018) Bogdana Suchorska et al. EUROPEAN JOURNAL OF CANCER
- Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma
- (2017) Benjamin M Ellingson et al. NEURO-ONCOLOGY
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
- (2016) Sidsel Højklint Poulsen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma
- (2016) Tae-Young Jung et al. NEUROSURGICAL REVIEW
- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
- (2015) Adriana Olar et al. ACTA NEUROPATHOLOGICA
- Prognostic value of volume-based measurements on 11C-methionine PET in glioma patients
- (2015) Kentaro Kobayashi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients
- (2015) Carles Majós et al. EUROPEAN RADIOLOGY
- Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
- (2015) B. Suchorska et al. NEUROLOGY
- Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
- (2014) Matthew M. Grabowski et al. JOURNAL OF NEUROSURGERY
- High-Grade Glioma Radiation Therapy Target Volumes and Patterns of Failure Obtained From Magnetic Resonance Imaging and 18F-FDOPA Positron Emission Tomography Delineations From Multiple Observers
- (2013) Robert Kosztyla et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- The Value of Glioma Extent of Resection in the Modern Neurosurgical Era
- (2012) Douglas A. Hardesty et al. Frontiers in Neurology
- Prognostic impact of postoperative, pre-irradiation 18F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy
- (2011) Marc D. Piroth et al. RADIOTHERAPY AND ONCOLOGY
- POSITRON EMISSION TOMOGRAPHY-GUIDED VOLUMETRIC RESECTION OF SUPRATENTORIAL HIGH-GRADE GLIOMAS
- (2009) Benoit J.M. Pirotte et al. NEUROSURGERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started